Delta variant doubles COVID-19 hospitalization risk in unvaccinated

A new study published in The Lancet is offering the most thorough investigation to date into the increased virulence of the SARS-CoV-2 Delta variant. The research found those infected with the Delta variant were twice as likely to be hospitalized compa… Continue reading Delta variant doubles COVID-19 hospitalization risk in unvaccinated

UK study identifies groups at risk of low response to COVID-19 vaccines

Early data from an ongoing UK study investigating COVID-19 vaccine responses in immunocompromised subjects indicates up to 60 percent of this cohort have effective immune responses to current vaccines. As well as identifying those patient sub-groups mo… Continue reading UK study identifies groups at risk of low response to COVID-19 vaccines

Global COVID-19 vaccine rollout hits 5-billion-dose milestone

Over five billion COVID-19 vaccine doses have now been administered around the world. This incredible milestone comes eight months after vaccinations commenced late in 2020, however, the World Health Organization (WHO) continues to express concern over… Continue reading Global COVID-19 vaccine rollout hits 5-billion-dose milestone

Pfizer COVID-19 vaccine is first to receive full FDA approval

The US Food and Drug Administration (FDA) has now fully approved Pfizer’s mRNA vaccine, making it the first COVID-19 vaccine to be completely authorized and marked as safe for use. The approval is hoped to instill confidence in those still hesitant to … Continue reading Pfizer COVID-19 vaccine is first to receive full FDA approval

US decision to offer COVID-19 vaccine boosters to all divides experts

From late September all Americans will be offered a third COVID-19 vaccine booster shot, to be administered at least eight months after a second dose. The formal booster announcement comes as the World Health Organization (WHO) and other experts questi… Continue reading US decision to offer COVID-19 vaccine boosters to all divides experts

New CDC data affirms mRNA COVID-19 vaccines are safe during pregnancy

New data from the US Centers for Disease Control and Prevention (CDC) is affirming the safety of mRNA COVID-19 vaccines during pregnancy. The ongoing surveillance project found no safety concerns for the vaccines or increased rates of miscarriage.Conti… Continue reading New CDC data affirms mRNA COVID-19 vaccines are safe during pregnancy

New CDC data affirms mRNA COVID-19 vaccines are safe during pregnancy

New data from the US Centers for Disease Control and Prevention (CDC) is affirming the safety of mRNA COVID-19 vaccines during pregnancy. The ongoing surveillance project found no safety concerns for the vaccines or increased rates of miscarriage.Conti… Continue reading New CDC data affirms mRNA COVID-19 vaccines are safe during pregnancy

FDA authorizes third COVID-19 mRNA vaccine dose for immunocompromised

The U.S. Food and Drug Administration (FDA) has authorized a third COVID-19 vaccine dose for some immunocompromised individuals. The authorization comes after several weeks of speculation about future vaccine booster plans and the FDA stresses other va… Continue reading FDA authorizes third COVID-19 mRNA vaccine dose for immunocompromised

Moderna COVID-19 vaccine safe & effective for teens, clinical trial finds

The results of a large Phase 3 trial testing Moderna’s COVID-19 vaccine in 12 to 17 year olds have been published in The New England Journal of Medicine. The study indicates the vaccine is as safe and effective as it was previously found to be in adult… Continue reading Moderna COVID-19 vaccine safe & effective for teens, clinical trial finds

Novavax positions its COVID-19 vaccine as “universal booster of choice”

Biotech company Novavax has announced it will be initially prioritizing regulatory submissions for its promising COVID-19 vaccine in countries with urgent needs such as India, Indonesia and the Philippines. The long-anticipated vaccine is also being tr… Continue reading Novavax positions its COVID-19 vaccine as “universal booster of choice”